Xarelto (rivaroxaban)

Wed, 29 Jun 2022 15:07:39 -0400
The treatment of venous thromboembolic events (VTE) and prevention of VTE recurrence in term neonates, infants and toddlers, children and adolescents aged less than 18 years after at least 5 days of initial parenteral anticoagulation treatment.